These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18440274)

  • 21. The evolving pathogenesis of systemic vasculitis.
    Savage CO
    Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of biologic therapies in the management of systemic vasculitis.
    Chan AT; Flossmann O; Mukhtyar C; Jayne DR; Luqmani RA
    Autoimmun Rev; 2006 Apr; 5(4):273-8. PubMed ID: 16697969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineutrophil cytoplasmic antibodies preferentially engage Fc gammaRIIIb on human neutrophils.
    Kocher M; Edberg JC; Fleit HB; Kimberly RP
    J Immunol; 1998 Dec; 161(12):6909-14. PubMed ID: 9862724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity--key to new therapies.
    Lamprecht P; Gross WL
    Trends Immunol; 2008 Dec; 29(12):587-8. PubMed ID: 18951843
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis.
    Little MA; Bhangal G; Smyth CL; Nakada MT; Cook HT; Nourshargh S; Pusey CD
    J Am Soc Nephrol; 2006 Jan; 17(1):160-9. PubMed ID: 16306166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein enhances the respiratory burst of neutrophils-induced by antineutrophil cytoplasmic antibody.
    Xu PC; Hao J; Yang XW; Chang DY; Chen M; Zhao MH
    Mol Immunol; 2012 Oct; 52(3-4):148-54. PubMed ID: 22683644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.
    Kain R; Firmin DA; Rees AJ
    Curr Opin Rheumatol; 2010 Jan; 22(1):15-20. PubMed ID: 19823088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of autoantibodies to myeloperoxidase on neutrophil function and intracellular signaling.
    Williams J; Hewins P; Savage C
    Jpn J Infect Dis; 2004 Oct; 57(5):S5-6. PubMed ID: 15507770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [NETs in pathogenesis of vasculitis].
    Nakazawa D; Nishio S; Tomaru U; Atsumi T; Ishizu A
    Nihon Jinzo Gakkai Shi; 2014; 56(2):117-23. PubMed ID: 24730349
    [No Abstract]   [Full Text] [Related]  

  • 31. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
    Hao J; Wang C; Yuan J; Chen M; Zhao MH
    PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulated neutrophil--endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention.
    Hu N; Westra J; Kallenberg CG
    Autoimmun Rev; 2011 Jul; 10(9):536-43. PubMed ID: 21513817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
    Pankhurst T; Savage CO
    Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the endothelium in systemic small vessel vasculitis.
    Little MA; Savage CO
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S135-40. PubMed ID: 18799071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil activation in anti-proteinase 3-positive vasculitis--a prospective study.
    Wikman A; Lundahl J; Jacobson SH
    Scand J Immunol; 2005 Dec; 62(6):539-45. PubMed ID: 16316421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophils and B lymphocytes in ANCA-associated vasculitis.
    Witko-Sarsat V; Daniel S; Noël LH; Mouthon L
    APMIS Suppl; 2009 Jun; (127):27-31. PubMed ID: 19515136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.
    Hao J; Meng LQ; Xu PC; Chen M; Zhao MH
    PLoS One; 2012; 7(5):e38317. PubMed ID: 22675451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANCA-associated vasculitis: is there a role for neutrophil apoptosis in autoimmunity?
    Harper L
    Expert Rev Clin Immunol; 2006 Mar; 2(2):237-44. PubMed ID: 20477074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
    Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
    Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.